Tom Luedde

Professor Tom Luedde serves as Head of the Department of Gastroenterology, Hepatology and Infectious Diseases at University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, and acts as Associate Editor for the Journal of Hepatology.

His academic training includes:

• Graduation from Medizinische Hochschule Hannover, Germany
• Board certification in Internal Medicine, Gastroenterology/Hepatology, Intensive Care Medicine and Infectious Diseases at University Hospital RWTH Aachen, Germany
• Research fellowship at Lineberger Cancer Centre, UNC North Carolina, USA (2000)
• Postdoctoral work at European Molecular Biology Laboratory and University of Cologne (2005-2007)

Luedde's research centers on inflammatory signaling and cell death mechanisms in NASH-driven liver cancer development, complemented by clinical investigations into AI-enhanced biomarkers for gastrointestinal tumors and health services research for severe GI disease/liver transplant patients. His prolific output spans 320+ peer-reviewed publications with a Web of Science H-index of 64.

Key recognitions include:

• Ernst Jung Career Advancement Award (2008)
• Thannhauser Award from DGVS (2011)
• EMBO Young Investigator Program membership (2012-2014)
• Mildred-Scheel Endowed Professorship

He maintains substantial research funding through an ERC Consolidator Grant (current) and prior ERC Starting Grant for liver cancer pathophysiology studies, while actively shaping the field through leadership in EASL events including the 2021 Basic Science Seminar and 2017/2019 HCC Summits.